Literature DB >> 12952359

Endocrine and metabolic alterations in obstructive sleep apnea syndrome.

F Lanfranco, L Gianotti, M Maccario.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12952359     DOI： 10.1007/BF03345208

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  8 in total

Review 1.  Testosterone therapy in men: clinical and pharmacological perspectives.

Authors:  A Gambineri; R Pasquali
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

2.  Obstructive sleep apnea syndrome induced by testosterone administration.

Authors:  R E Sandblom; A M Matsumoto; R B Schoene; K A Lee; E C Giblin; W J Bremner; D J Pierson
Journal:  N Engl J Med       Date:  1983-03-03       Impact factor: 91.245

3.  Pathophysiological mechanisms in obstructive sleep apnea.

Authors:  C E Sullivan; F G Issa
Journal:  Sleep       Date:  1980       Impact factor: 5.849

4.  Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men.

Authors:  C Rolf; S Kemper; G Lemmnitz; U Eickenberg; E Nieschlag
Journal:  Eur J Endocrinol       Date:  2002-05       Impact factor: 6.664

5.  Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment.

Authors:  B G Cooper; J E White; L A Ashworth; K G Alberti; G J Gibson
Journal:  Sleep       Date:  1995-04       Impact factor: 5.849

6.  Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep.

Authors:  A M Matsumoto; R E Sandblom; R B Schoene; K A Lee; E C Giblin; D J Pierson; W J Bremner
Journal:  Clin Endocrinol (Oxf)       Date:  1985-06       Impact factor: 3.478

7.  Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy.

Authors:  R R Grunstein; D J Handelsman; S J Lawrence; C Blackwell; I D Caterson; C E Sullivan
Journal:  J Clin Endocrinol Metab       Date:  1989-02       Impact factor: 5.958

8.  Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters.

Authors:  A Gambineri; C Pelusi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256
  8 in total
  1 in total

1.  Double blind randomized placebo-controlled trial on the effects of testosterone supplementation in elderly men with moderate to low testosterone levels: design and baseline characteristics [ISRCTN23688581].

Authors:  Hamid Reza Nakhai Pour; Marielle H Emmelot-Vonk; Marja Sukel-Helleman; Harald J J Verhaar; Diederick E Grobbee; Yvonne T van der Schouw
Journal:  Trials       Date:  2006-08-03       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.